Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00033059Phase 1Unknown
Assessment of Potential Interactions Between Cocaine and Tolcapone - 1
Cocaine-Related Disorders
Principalinvestigator
NCT00040040Phase 1Unknown
Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
Amphetamine-Related Disorders
Principalinvestigator
NCT00040053Phase 2Completed
Ondansetron for the Treatment of Methamphetamine Dependence - 1
Amphetamine-Related Disorders
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Institute on Drug Abuse (NIDA)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aviv M Weinstein, Ph.D

Hadassah Medical Organization

Moderately Similar
3 trials

Shared therapeutic areas:

Amphetamine-Related DisordersCocaine-Related Disorders
Similarity Score30%

Walter Ling, M.D.

Friends Research Institute, Inc.

Moderately Similar
28 trials

Shared therapeutic areas:

Cocaine-Related DisordersAmphetamine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)University of California, Los Angeles
Similarity Score30%

Laure Buydens-Branchey, M.D.

VA Medical Center

Related
3 trials

Shared therapeutic areas:

Cocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Louis Cantilena, M.D.

Uniformed Services University of Health Science

Related
7 trials

Shared therapeutic areas:

Cocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Gantt Galloway, PharmD

California Pacific Medical Center

Related
3 trials

Shared therapeutic areas:

Amphetamine-Related Disorders
Similarity Score15%

Jack Mendelson, M.D.

Mclean Hospital

Related
3 trials

Shared therapeutic areas:

Cocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Eugene Somoza, M.D., Ph.D.

Cincinnati MDRU

Related
7 trials

Shared therapeutic areas:

Cocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Richard Foltin, Ph.D.

Columbia University

Related
4 trials

Shared therapeutic areas:

Cocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Yodphat Krausz, MD

Hadassah Medical Organization

Related
3 trials

Shared therapeutic areas:

Amphetamine-Related Disorders
Similarity Score15%

Eric C Strain, M.D.

Johns Hopkins University

Related
3 trials

Shared therapeutic areas:

Cocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00033059Phase 1PrincipalInvestigator

Assessment of Potential Interactions Between Cocaine and Tolcapone - 1

Cocaine-Related Disorders
Unknown
NCT00040040Phase 1PrincipalInvestigator

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Amphetamine-Related Disorders
Unknown
NCT00040053Phase 2PrincipalInvestigator

Ondansetron for the Treatment of Methamphetamine Dependence - 1

Amphetamine-Related Disorders
Completed

All 3 trials loaded